The primary objective of this study is to evaluate the safety and effectiveness of the
AtriCure CryoICE system in performing the Cox-Maze III lesion set, in conjunction with Left
Atrial Appendage (LAA) exclusion using the AtriClip device.
The AtriCure CryoICE Ablation System is being studied to ablate cardiac tissue during surgery
for the treatment of Persistent and Long-standing Persistent atrial fibrillation in open
concomitant cardiac surgery.
The effectiveness of the device will be demonstrated by establishing that the device
effectively eliminates persistent and long-standing persistent atrial fibrillation in a
clinically significant proportion of treated patients.
AtriCure CryoICE & AtriClip LAA Exclusion
Clinical Study Identifier
Last Modified on
13 August 2020
How clear was the trial content above?
Adding a note
Select a piece of text and start making personal notes.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.